Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nexoptic Technology Corp V.NXO

Alternate Symbol(s):  NXOPF

NexOptic Technology Corp. is a Canada-based technology company. The Company is engaged in developing artificial intelligence (AI) and imaging products, which enhance how images are either captured, processed, experienced, transferred and/or stored. The Company's primary focus is its AI for imaging called All Light Intelligent Imaging Solutions (Aliis). Aliis is a machine-learning AI suite providing instant enhancement to images and videos in the areas of edge processing, shutter speed, resolution and sharpness, image-noise and motion-blur, and image color and detail. Aliis processes raw images and video in real time, working pixel-by-pixel to characteristics, such as resolution, lighting, sharpness and contrast. Its DoubleTake technology features both wide-angle and telephoto cameras, allowing near-instant spotting and zooming capabilities. Its NexCompress, a video compression enhancement solution, offers bandwidth and storage savings for video storage and streaming applications.


TSXV:NXO - Post by User

Post by BarstoolSageon Oct 28, 2022 9:33pm
216 Views
Post# 35057317

Updated facts

Updated factsThe financing was necessary to survive and has been announced but not yet closed.

The financing is dilutive with significant added share count and low priced warrants

There have been no announced NXO revenue contracts beyond the Pristine Surgical deal which if Pristine begins to earn revenues 4Q/2022 means NXO gets cash in say mid 23 if any is owed

The Selten deal does not appear to have closed

ALL ELSE IS NOISE
<< Previous
Bullboard Posts
Next >>